SCHEMBL29958548

SCHEMBL29958548

N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 12/20 0.49
▸ NPY1R P25929 7/20 0.49
▸ NPY2R P49146 5/20 0.49
▸ NPY5R Q15761 5/20 0.49
▸ GNPAT O15228 1/20 0.44
▸ FNTA P49354 3/20 0.43
▸ FNTB P49356 3/20 0.43
▸ PGGT1B P53609 3/20 0.43
▸ TUBB4A P04350 1/20 0.42
▸ TUBB P07437 1/20 0.42
▸ TUBA3C P0DPH7 1/20 0.42
▸ TUBA1B P68363 1/20 0.42
▸ TUBA4A P68366 1/20 0.42
▸ TUBB4B P68371 1/20 0.42
▸ TUBB3 Q13509 1/20 0.42
▸ TUBB2A Q13885 1/20 0.42
▸ TUBB8 Q3ZCM7 1/20 0.42
▸ TUBA3E Q6PEY2 1/20 0.42
▸ TUBA1A Q71U36 1/20 0.42
▸ TUBA1C Q9BQE3 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29420164 0.99 NPY4R (0.47) NPY4RNPY1RNPY2RNPY5RGNPAT
SCHEMBL30152128 0.99 NPY4R (0.47) NPY4RNPY1RNPY2RNPY5RGNPAT
SCHEMBL30475878 0.95 NPY4R (0.46) NPY4RNPY1RNPY2RNPY5RTUBB4A
SCHEMBL29913275 0.94 NPY4R (0.46) NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL30216757 0.94 NPY4R (0.46) NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL29461968 0.94 NPY4R (0.46) NPY4RNPY1RNPY2RNPY5RGNPAT
SCHEMBL30418999 0.94 NPY4R (0.51) NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL30948383 0.94 NPY4R (0.45) NPY4RNPY1RNPY2RNPY5RTUBB4A
SCHEMBL29452752 0.93 NPY4R (0.45) NPY4RNPY1RNPY2RNPY5RTUBB4A
SCHEMBL30272461 0.93 NPY4R (0.44) NPY4RNPY1RNPY2RNPY5RFNTA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240156974-A1 COMPOSITIONS AND METHODS FOR MODULATION OF ANTIBODY ACTIVITY INSTITUTE FOR CANCER RES D/B/A THA RES INSTITUTE OF FOX CHASE CANCER CENTER (US) 2024-05-16 — — US disclosed
WO-2022197883-A1 COMPOSITIONS AND METHODS FOR MODULATION OF ANTIBODY ACTIVITY INSTITUTE FOR CANCER RESEARCH D/B/A (US) 2022-09-22 — — WO disclosed
Send feedback